Breaking News

NanoViricides Appoints Id3A for cGMP Facility

Will be responsible for architecture and integration of clean room suite

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NanoViricides, Inc. has retained Id3A, LLC as the architect for its lab and cGMP pilot production facility. The facility will be built by renovating an existing 18,000-sq.-ft. light manufacturing plant in Shelton, CT. The cGMP pilot plant is being designed for the production of sufficient quantities of the drug needed for human clinical trials for each of the various nanoviricides drug candidates entering trials.   Kathyann Cowles, AIA, will serve as the principal architect for the project. Id3A...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters